Thomas Patrick Kelly, Chief Financial Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 2,316 shares at $12.02 ($28K) on 2023-10-30, disclosed to the SEC on 2023-10-31.
Open-market sale of $28k DCPH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-06-21 | $24K | — | Filing → |
| DCPH | SELL | 2023-02-17 | $21K | — | Filing → |